About: Levemir   Sponge Permalink

An Entity of Type : owl:Thing, within Data Space : dbkwik.org associated with source dataset(s)

Levemir is 's worldwide brand name for insulin detemir, a long-lasting insulin analog that lasts up to 24 hours in humans. Its chief benefits according to Novo are a "peakless" action, less weight gain than other insulins, and less day-to-day variability than NPH or Lantus insulins. Levemir has been shown (by the manufacturer) to vary less day-to-day than NPH or Lantus. It was also found to vary less between patients.

AttributesValues
rdfs:label
  • Levemir
rdfs:comment
  • Levemir is 's worldwide brand name for insulin detemir, a long-lasting insulin analog that lasts up to 24 hours in humans. Its chief benefits according to Novo are a "peakless" action, less weight gain than other insulins, and less day-to-day variability than NPH or Lantus insulins. Levemir has been shown (by the manufacturer) to vary less day-to-day than NPH or Lantus. It was also found to vary less between patients.
Strength
  • U100
openedlife
  • 6(xsd:integer)
penlife
  • 6(xsd:integer)
dogaction
  • *use 1/4 usual dose for dogs! *onset Xh , *peak Xh, *duration Xh See Fleeman-Rand protocol
handlingnotes
  • *protect from light and heat *Do Not Freeze *do not refrigerate after opening *no need to roll before use *mixing with other insulins may change action of one or both *dilution effects unknown *Do not use intravenously * Avoid intramuscular use
mfg
shelflife
  • 6.31152E7
cloudyorsoluble
  • clear
cataction
  • -86400.0
generic
  • detemir
dcterms:subject
Origin
Name
  • Levemir
Similar
dbkwik:petdiabetes...iPageUsesTemplate
Line
  • new molecular entity
Aliases
  • Detemir
fgcolor
  • #000080
BGCOLOR
  • #d1eeee
- align
  • "center" style="background:#cae1ff;border-bottom:3px solid grey;"
Action
Suspension
  • Special-via albumin binding
abstract
  • Levemir is 's worldwide brand name for insulin detemir, a long-lasting insulin analog that lasts up to 24 hours in humans. Its chief benefits according to Novo are a "peakless" action, less weight gain than other insulins, and less day-to-day variability than NPH or Lantus insulins. Levemir has been shown (by the manufacturer) to vary less day-to-day than NPH or Lantus. It was also found to vary less between patients.
Alternative Linked Data Views: ODE     Raw Data in: CXML | CSV | RDF ( N-Triples N3/Turtle JSON XML ) | OData ( Atom JSON ) | Microdata ( JSON HTML) | JSON-LD    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3217, on Linux (x86_64-pc-linux-gnu), Standard Edition
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2012 OpenLink Software